$177,503
－55.2%
Chief Financial Officer
2021
$178k
40 hrs/wk
Chief Financial Officer at The Leukemia & Lymphoma Societyinc Inc.
Fiscal year ended June 30, 2021. Published on January 25, 2026.
Total compensation
Rosemarie Aloffredo - End 3312019 has been listed as an employee of The Leukemia & Lymphoma Societyinc Inc. in Form 990 filings since fiscal year 2020. Total compensation for Rosemarie Aloffredo - End 3312019 has decreased by 55.2% from 2020 to 2021.